Literature DB >> 16534685

Budd-Chiari syndrome in an afibrinogenemic patient: a paradoxical complication.

Nevin Oruc1, Yaman Tokat, Refik Killi, Murat Tombuloglu, Tankut Ilter.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16534685     DOI： 10.1007/s10620-006-3141-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  21 in total

1.  Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update.

Authors:  G Maresca; A Di Blasio; R Marchioli; G Di Minno
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-06       Impact factor: 8.311

2.  Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.

Authors:  M H Denninger; Y Chaït; N Casadevall; S Hillaire; M C Guillin; A Bezeaud; S Erlinger; J Briere; D Valla
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

Review 3.  Fibrin and its derivatives in the normal and diseased vessel wall.

Authors:  A Bini; B J Kudryk
Journal:  Ann N Y Acad Sci       Date:  1992-12-04       Impact factor: 5.691

4.  Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.

Authors:  Q Xiao; M J Danton; D P Witte; M C Kowala; M T Valentine; J L Degen
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

5.  Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology.

Authors:  J Soria; C Soria; J Y Borg; M Mirshahi; H Piguet; P Tron; C Fessard; J P Caen
Journal:  Br J Haematol       Date:  1985-07       Impact factor: 6.998

Review 6.  Congenital afibrinogenemia.

Authors:  H al-Mondhiry; W C Ehmann
Journal:  Am J Hematol       Date:  1994-08       Impact factor: 10.047

7.  Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin.

Authors:  E Dupuy; C Soria; P Molho; J M Zini; S Rosenstingl; C Laurian; P Bruneval; G Tobelem
Journal:  Thromb Res       Date:  2001-05-01       Impact factor: 3.944

Review 8.  Rare coagulation deficiencies.

Authors:  F Peyvandi; S Duga; S Akhavan; P M Mannucci
Journal:  Haemophilia       Date:  2002-05       Impact factor: 4.287

9.  Characterization of fibrinogen New York 1. A dysfunctional fibrinogen with a deletion of B beta(9-72) corresponding exactly to exon 2 of the gene.

Authors:  C Y Liu; J A Koehn; F J Morgan
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

10.  Clinical spectrum, investigations and treatment of Budd-Chiari syndrome.

Authors:  A E Mahmoud; A Mendoza; A N Meshikhes; S Olliff; R West; J Neuberger; J Buckels; J Wilde; E Elias
Journal:  QJM       Date:  1996-01
View more
  4 in total

1.  Massive hemoperitoneum due to a ruptured corpus luteum cyst in a patient with congenital hypofibrinogenemia.

Authors:  Jong-Hyun Kim; So-Young Jeong; Dong-Hyu Cho
Journal:  Obstet Gynecol Sci       Date:  2015-09-22

Review 2.  The clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency.

Authors:  Antonio Girolami; Nicole Candeo; Silvia Vettore; Anna Maria Lombardi; Bruno Girolami
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

3.  Recurrent massive haemoperitoneum associated with ruptured corpus luteum in women with congenital afibrinogenemia; case report.

Authors:  Özhan Özdemir; Mustafa Erkan Sarı; Aslıhan Kurt; Ertuğrul Şen; Cemal Reşat Atalay
Journal:  Turk J Obstet Gynecol       Date:  2014-12-15

Review 4.  Treatment of congenital fibrinogen deficiency: overview and recent findings.

Authors:  Konstantinos Tziomalos; Sofia Vakalopoulou; Vassilios Perifanis; Vassilia Garipidou
Journal:  Vasc Health Risk Manag       Date:  2009-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.